Introduction: Unraveling the Epigenetic Landscape of Breast Cancer “Breast cancer is the most commonly diagnosed malignancy in women. Despite advances in diagnostics and treatment, the key molecular mechanisms underlying its development remain incompletely understood.” This […]
Comparison of robotic, conventional, and endoscopic nipple-sparing mastectomy with immediate prosthetic breast reconstruction for breast cancer: A systematic review and meta-analysis Introduction: The Challenge of Breast Cancer Treatment Breast cancer is a leading cause of […]
Exploring the Gut-Immune-Cancer Axis in Breast Cancer Risk Breast cancer is one of the most common malignancies affecting women worldwide and remains a leading cause of cancer-related deaths. According to the article published in Biomolecules […]
New Study Explores Deep Learning to Improve Breast Cancer Diagnosis Using Routine CT Scans Breast cancer remains the most common malignancy among women globally and is a major cause of cancer-related death. According to the […]
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]
Breast cancer is the most common type of cancer in women, aside from skin cancers. Studies have demonstrated that keeping track of cancer treatment can enhance patient results. Due to the absence of a centralized […]
By Semir Vranic, MD, PhD Bosnian Journal of Basic Medical Sciences Editor in Chief Food and Drug Administration (FDA) has just granted accelerated approval to sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.) for the patients with metastatic […]
Background According to World Health Organization (WHO), cancer is the second major source of death worldwide. In general, lung, breast and colorectal cancer are the most prevalent types of cancer. Treatment strategies mainly rely on […]
Apocrine carcinoma of the breast is a rare, primary breast cancer characterized by the apocrine morphology, estrogen receptor-negative and androgen receptor-positive profile with a frequent overexpression of Her-2/neu protein. The frequent presence of PIK3CA mutations […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH